Here, we describe a protocol for generating maternal mutant that couples a stable zpc:cas9 knock-in line with Tol2-mediated delivery of sgRNA expression cassettes.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Here, we describe a protocol for generating maternal mutant that couples a stable zpc:cas9 knock-in line with Tol2-mediated delivery of sgRNA expression cassettes.
Oogenesis and early embryonic development are critically dependent on maternally derived mRNAs and proteins. Eliminating these maternal factors necessitates homozygous mutations in female zebrafish, often resulting in lethal or infertile phenotypes, which prevent the acquisition of maternal mutant embryos. Our previous work introduced a rapid approach to bypass zygotic lethality through oocyte-specific genome editing. However, the previously reported cas9 transgene exhibits instability and undergoes gradual silencing over successive generations. Furthermore, the presence of Tol2 transposable elements flanking the zpc:cas9 cassette in this line hinders the potential for further sgRNA transgenesis using Tol2 system, which is currently the most efficient transgenic system in zebrafish. Consequently, there is a critical need for a Tol2-free zebrafish line that ensures stable and robust oocyte-specific Cas9 expression. Here, we present a line with zpccas9 knock-in at the rbm24a locus that addresses this requirement. Using this enhanced tool, we provide a pipeline for the rapid generation of maternal mutants of genes with zygotically lethal mutant phenotypes within the zebrafish model.
The early embryonic development of vertebrates relies heavily on the RNA and proteins stored within the egg, collectively referred to as maternal factors. These maternal products are predominantly synthesized during the diplotene stage of meiosis I1,2,3. To investigate their functional roles, it is essential to generate homozygous mutant female individuals, as only homozygous mutation in the oocytes can fully deplete these maternal factors. However, obtaining such homozygous mutant females becomes challenging when zygotic homozygous mutations result in lethality or sterility<....
Access restricted. Please log in or start a trial to view this content.
The experiments were carried out in accordance with ARRIVE guidelines and were ethically approved by Shandong University's Institutional Animal Care Committee (Approval No. SYDWLL-2021-15). The overview of this protocol is shown in Figure 2.
1. Generation of the rbm24a-RFP zpc:cas9 knock-in line
Access restricted. Please log in or start a trial to view this content.
Rapid generation of rbm24a maternal mutants
We constructed a transgenic vector enabling expression of a maternal BFP marker and four highly efficient sgRNAs targeting the rbm24a coding sequence. Following the introduction of this vector into homozygous rbm24a-RFP KIzpc:cas9 embryos via Tol2 transposition, Mrbm24a was easily and rapidly identified among BFP-positive F1 embryos due to the absence of Rbm24a-RFP pro.......
Access restricted. Please log in or start a trial to view this content.
Lethal zygotic mutations hinder analysis of a gene's maternal contribution. Alternative strategies, most notably germline replacement and Oocyte Microinjection In Situ (OMIS), are technically demanding6,8. In cell transplantation process of germline replacement, the recipient embryo receives very few PGCs, often preventing normal female development16,17,18. Using ind.......
Access restricted. Please log in or start a trial to view this content.
This protocol has been granted as a patent by the China National Intellectual Property Administration, which will relieve the restricted usage of the method after gaining the permission of the authors. The authors declare that they have no other competing or financial interests.
We thank Jianlin Shen, Yiteng Xu, and Qingqing Wei from the Core Facility and Service Platform, School of Lifesciences. This work was supported by the National Natural Science Foundation of China (grants 32170816, 32370860, 32450630, and 31871451), Program of Outstanding Middle-aged and Young Scholars of Shandong University, the Taishan Scholars of Shandong Province.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 2x M5 HiPer Taq PCR mix | Mei5bio | Cat#MF001-BD-100 | |
| Agarose | MDbio | Cat#A006L | |
| AxyPrep Plasmid Miniprep Kit | Axygen | Cat#AP-MN-P-4 | |
| Capillary electrophoresis instrument (Qsep400) | BiOptic | N/A | |
| DIG-labeling mix | Roche | Cat#11277073910 | |
| DNase I | Roche | Cat#4716728001 | |
| DTT | Thermo Fisher Scientific | Cat#R0861 | |
| First-strand cDNA synthesis kit | TransGen Biotech | Cat#AT301 | |
| GenCrispr NLS-Cas9-NLS Nuclease | GenScript | Cat#Z03389 | |
| Glass capillaries (1.0 x 100 mm) | Rantai Educational Equipment Factory | Cat#OS-2B | |
| Glycogen | BBI Life Science | Cat#28985 | |
| GraphPad Prism 9 | GraphPad | https://www.graphpad.com/ | |
| ImageJ | Open source | https://imagej.net/software/fiji/ | |
| Low-melting agarose | Biotech | Cat#CA1351 | |
| Microforge (MF2) | NARISHIGE | N/A | |
| Micro-spectrophotometer (Nano-300) | ALLSHENG | N/A | |
| OlyVIA | OLYMPUS | N/A | |
| Penicillin-streptomycin | Gibco | Cat#15140122 | |
| Pico-Liter Injector (PLI-100A) | Harvard Apparatus | N/A | |
| Pointed tweezers | WPI | Cat#500341 | |
| Pointed tweezers | WPI | 500341 | |
| Puller (PC-100) | NARISHIGE | N/A | |
| RiboLock RNase Inhibitor | Thermo Fisher Scientific | Cat#EO0381 | |
| rNTP | Thermo Fisher Scientific | Cat#R0481 | |
| Silicon hydroxyl magnetic beads | Sangon Biotech | Cat#B518720-0001 | |
| T7 RNA polymerase | NEB | Cat#M0251L | |
| Zold | WPI | Cat# z-molds |
Access restricted. Please log in or start a trial to view this content.